Whitlow E,Mustafa AS,Hanif SNM .2020 .An Overview of the Development of New Vaccines for Tuberculosis. , 8(4) : 586.
Organization WH .2020 .. ) Global Tuberculosis Report, : .
Geneva .2021 .. , : .
MacNeil A,Glaziou P,Sismanidis C,Date A,Maloney S .2020 .Global epidemiology of tuberculosis and progress toward meeting global targets-worldwide. Morbidity and Mortality Weekly Report, 69(11) : 281.
. .Immunogenicity and protective efficacy against murine tuberculosis of a prime-boost regimen with BCG and a DNA vaccine expressing ESAT-6 and Ag85A fusion protein. , : .
Clinical Developmental,Immunology Developmental .2011 .; 2011(1. , : 1-10.
Tang ,Johnston SA .1992 .Genetic immunization is a simple method for eliciting an immune response. Nature, 356(6365) : 152-154.
Huygen K. Plasmid .2005 .Microbes and infection. , 7(5) : 932-938.
.2009 .Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; preclinical characterization, safety and protection against challenge with Mycobacterium tuberculosis. Vaccine, 27(33) : 4412-4423.
Montagnani C,Chiappini E,Galli L,de Martino M. .2014 .Vaccine against tuberculosis: what's new? BMC infectious diseases. , 14(1) : 1-9.
.2018 .Potential of DosR and Rpf antigens from Mycobacterium tuberculosis to discriminate between latent and active tuberculosis in a tuberculosis endemic population of Medellin Colombia. BMC Infectious Diseases, : 181-9.
Hamada Y,Cirillo DM,Matteelli A,Penn-Nicholson A,Rangaka MX .2021 .Tests for tuberculosis infection: landscape analysis. European Respiratory Journal, 58(5) : .
Tameris M,Mearns H,Penn-Nicholson A,Gregg Y,Bilek N .2019 .Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial. The lancet Respiratory medicine, 7(9) : 757-770.
Spertini F,Audran R,Chakour R,Karoui O,Steiner-Monard V .2015 .Safety of human immunisation with a liveattenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial. The lancet Respiratory medicine. , 3(12) : 953-962.
.2019 .Empirical evidence of delays in diagnosis and treatment of pulmonary tuberculosis: systematic review and metaregression analysis. BMC public health, 19(1) : 1-11.
Mu J,Jeyanathan M,Small C-L,Zhang X,Roediger E .2009 .Immunization with a bivalent adenovirus-vectored tuberculosis vaccine provides markedly improved protection over its monovalent counterpart against pulmonary tuberculosis. Molecular Therapy, 17(6) : 1093-1100.
Mobed .2020 .A. DNA Based vaccines against Mycobacterium tuberculosis: recent progress in vaccine development and delivery system. Iranian Journal of Immunology, 17(4) : 255-274.
Kowalewicz-Kulbat M,Locht C .2022 .Recombinant BCG to enhance its immunomodulatory activities. Vaccines, 10(5) : 827.
Arlehamn CSL,Lewinsohn D,Sette A,Lewinsohn D .2014 .; 4(7): a018465.. , : .
Buzitskaya Z,Stosman K,Khairullin B,Kassenov M,Nurpeisova A .2022 .A new intranasal influenza vectorbased vaccine TB/FLU-04L against tuberculosis: preclinical safety studies. Drug Research, 72(05) : 255-258.
Fomsgaard A,Liu MA .2021 .The key role of nucleic acid vaccines for one health. Viruses, 13(2) : 258.
Chung C,Niemela SL,Miller RH .1989 .One-step preparation of competent Escherichia coli: transformation and storage of bacterial cells in the same solution. Proceedings of the National Academy of Sciences, 86(7) : 2172-2175.
Sefidi-Heris Y,Jahangiri A,Mokhtarzadeh A,Shahbazi M-A,Khalili S .2020 .Recent progress in the design of DNA vaccines against tuberculosis. Drug Discovery Today, 25(11) : 1971-1987.
Fan X,Gao Q,Fu R .2009 .Differential immunogenicity and protective efficacy of DNA vaccines expressing proteins of Mycobacterium tuberculosis in a mouse model. Microbiological research, 164(4) : 374-382.
Ilghari D,Lightbody KL,Veverka V,Waters LC,Muskett FW .2011 .Solution structure of the Mycobacterium tuberculosis EsxG· EsxH complex: functional implications and comparisons with other M. tuberculosis Esx family complexes. Journal of Biological Chemistry, 286(34) : 29993-30002.
Shahzad MI,Shahid N,Sial N,Hasanat A,Khalid M .2017 .Evaluation of DNA vaccines encoding M. Tb gene Bfrb and Mpt32 in mice model. Pakistan journal of pharmaceutical sciences,, 30(5) : 2025-2029.
Shahzad MI,Khan IH,Luciw PA,Gulfraz M,Khanum A.,Cloning A. .2013 .Genetic Immunization Studies of Mycobacterium tuberculosis Gene esat6. Pakistan Journal of Zoology, 45(3) : .
Shahzad M. .2021 .DNA vaccine against tuberculosis by using five Mycobacterium specific genes. International Journal of Mycobacteriology, 10(5) : 4-4.
Lopes RL,Borges TJ,Araújo JF,Pinho NG,Bergamin LS .2014 .Extracellular mycobacterial DnaK polarizes macrophages to the M2-like phenotype. PLoS One, 9(11) : e113441.
Vinod V,Pushkaran AC,Kumar A,Mohan CG,Biswas R,Acta (BBA)-General Subjects .2021 .; 1865(1. Biochimica, : 129758.
Esparza M,Palomares B,García T,Espinosa P,Zenteno E,Phagocytosis Promotes . .PstS‐1, the 38‐kDa M ycobacterium tuberculosis Glycoprotein, is an Adhesin, Which Binds the Macrophage Mannose Receptor. , : .
.2015 .. Scandinavian journal of immunology, 81(1) : 46-55.
Maurya VK,Singh K,Sinha S K .2014 .Suppression of Eis and expression of Wag31 and GroES in Mycobacterium tuberculosis cytosol under anaerobic culture conditions. , 52(08) : 773-780.
Ofori-Anyinam N,Hamblin M,Coldren ML,Li B,Mereddy G .2017 .KatG catalase deficiency confers bedaquiline hypersusceptibility to isoniazid resistant Mycobacterium tuberculosis. , 562707 : .
XIAO LI X,LI T,LIU M,LI S H .2019 .Evaluation of the antigenicity of Dnak and MPT83 proteins of Mycobacterium tuberculosis. Chinese Journal of Microbiology and Immunology, : 106-113.
Fan X,Li X,Wan K,Zhao X,Deng Y .2021 .Construction and immunogenicity of a T cell epitope-based subunit vaccine candidate against Mycobacterium tuberculosis. Vaccine, 39(47) : 6860-6865.
. .To read the copy of this license please visit: https://creativecommons. , : .